The twisting, turning saga of Illumina and Ariosa Diagnostics has taken another detour.

On Monday the U.S. Supreme Court referred an issue from the six-year-old dispute over fetal diagnostics to the Solicitor General’s Office for its views, raising the likelihood that it may wind up on the high court’s docket next year.